Searchable abstracts of presentations at key conferences in endocrinology

ea0050p319 | Obesity and Metabolism | SFEBES2017

The adverse metabolic phenotype associated with obstructive sleep apnoea is not driven by activation of the hypothalamo-pituitary-adrenal axis

Hazlehurst Jonathan M , Charlton Catriona , Mantripp Diana , Hodson Leanne , Tomlinson Jeremy W

Glucocorticoid (GC) excess drives obesity, insulin resistance and type 2 diabetes. Obstructive sleep apnoea (OSA) is a prevalent condition associated with both activation of the hypothalamic-pituitary-adrenal (HPA) axis and an adverse metabolic phenotype. However, a causal link between these two features has not been established. We designed a novel human model of intermittent hypoxia (IH) aimed at replicating the systemic insulin resistance associ...

ea0050p319 | Obesity and Metabolism | SFEBES2017

The adverse metabolic phenotype associated with obstructive sleep apnoea is not driven by activation of the hypothalamo-pituitary-adrenal axis

Hazlehurst Jonathan M , Charlton Catriona , Mantripp Diana , Hodson Leanne , Tomlinson Jeremy W

Glucocorticoid (GC) excess drives obesity, insulin resistance and type 2 diabetes. Obstructive sleep apnoea (OSA) is a prevalent condition associated with both activation of the hypothalamic-pituitary-adrenal (HPA) axis and an adverse metabolic phenotype. However, a causal link between these two features has not been established. We designed a novel human model of intermittent hypoxia (IH) aimed at replicating the systemic insulin resistance associ...

ea0086op1.2 | Thyroid | SFEBES2022

Long-term mortality and cardiometabolic effects of treatment for hyperthyroidism: EGRET study

Torlinska Barbara , Hazlehurst Jonathan M. , Nirantharakumar Krishnarajah , Neil Thomas G. , Priestley Julia , Abrams Keith R. , Boelaert Kristien

Hyperthyroidism has been linked to long-term cardiovascular and metabolic morbidity and increased mortality. We aimed to assess differences in mortality and cardiometabolic outcomes depending on treatment modality to better inform patient-clinician decision-making.Methods: We identified 62,474 patients with newly diagnosed hyperthyroidism, treated with antithyroid drugs (ATD), radioiodine or thyroidectomy from a UK population-based GP database (>16M ...